(1-((1,3-Diphenyl-1H-pyrazol-4-yl)methyl)-1H-1,2,3-triazol-4-yl)methanol

ID: ALA4216760

PubChem CID: 145971654

Max Phase: Preclinical

Molecular Formula: C19H17N5O

Molecular Weight: 331.38

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  OCc1cn(Cc2cn(-c3ccccc3)nc2-c2ccccc2)nn1

Standard InChI:  InChI=1S/C19H17N5O/c25-14-17-13-23(22-20-17)11-16-12-24(18-9-5-2-6-10-18)21-19(16)15-7-3-1-4-8-15/h1-10,12-13,25H,11,14H2

Standard InChI Key:  YAAOFRQETIMQJJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
    3.0995  -13.4548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9208  -13.4548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1793  -12.6740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5122  -12.1877    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8494  -12.6740    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5110  -11.3665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2239  -10.9575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2230  -10.1369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5100   -9.7244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7964  -10.1426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8008  -10.9618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3212  -14.1605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1384  -14.1667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6827  -14.1605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8621  -14.1496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4453  -14.8545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8482  -15.5693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6720  -15.5749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0850  -14.8694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6155  -14.8301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3946  -14.5834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4008  -13.7662    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6255  -13.5080    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0521  -15.0688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8011  -14.7420    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  1  2  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
  4  6  1  0
  2 12  1  0
 12 13  1  0
  1 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 13 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 13  1  0
 21 24  1  0
 24 25  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4216760

    ---

Associated Targets(Human)

U-937 (7138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Salmonella paratyphi (588 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 331.38Molecular Weight (Monoisotopic): 331.1433AlogP: 2.67#Rotatable Bonds: 5
Polar Surface Area: 68.76Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.87CX Basic pKa: 1.37CX LogP: 3.18CX LogD: 3.18
Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.61Np Likeness Score: -1.90

References

1. Dayakar C, Kumar BS, Sneha G, Sagarika G, Meghana K, Ramakrishna S, Prakasham RS, China Raju B..  (2017)  Synthesis, pharmacological activities and molecular docking studies of pyrazolyltriazoles as anti-bacterial and anti-inflammatory agents.,  25  (20): [PMID:28927905] [10.1016/j.bmc.2017.08.042]

Source